Cancer Treatment in Vietnam vs Thailand: What Should You Know

Vietnam and Thailand both have hospitals capable of treating cancer with surgery, chemotherapy, radiotherapy and modern systemic therapies. For an international patient, however, choosing between the two countries is rarely as simple as deciding which healthcare system is better.

Thailand has a more established private hospital sector built around international patients, particularly in Bangkok. Vietnam has major specialist oncology hospitals and increasingly sophisticated private cancer centres, with the strongest options concentrated in Hanoi, Ho Chi Minh City and Hue.

The right choice depends on the cancer itself. A patient needing standard chemotherapy may find everything required close to home in Vietnam, while someone seeking a particular specialist, radiation technology or highly coordinated international service may have reasons to compare Bangkok as well.

The first comparison is the tumour, not the country

Before comparing Vietnam and Thailand, establish exactly what treatment is required.

Cancer is not one disease. Treatment depends on factors such as:

• Cancer type.
• Stage.
• Pathology.
• Molecular or biomarker results.
• Previous treatment.
• General health.
• Whether surgery is possible.
• Whether radiotherapy is required.

Someone with early breast cancer needs a different healthcare team from someone with metastatic lung cancer, lymphoma or a complex liver tumour.

A country-level comparison can help with logistics, but the final decision should usually be made between specific oncology teams and hospitals.

Vietnam has more cancer treatment capability than many patients expect

Vietnam treats a substantial cancer burden. The International Agency for Research on Cancer estimated 180,480 new cancer cases in Vietnam in 2022, with breast, liver and lung cancer the three most frequently diagnosed cancers across both sexes.

The country's oncology system includes large specialist public hospitals as well as private hospital networks.

In Hanoi, Vietnam National Cancer Hospital, commonly known as K Hospital, is a major specialist oncology institution. Hanoi also has private oncology services through hospitals such as Vinmec Times City.

Ho Chi Minh City has large public oncology services and private options including Vinmec Central Park, whose Oncology Center publishes services covering surgery, radiotherapy, chemotherapy and palliative care.

Hue Central Hospital operates one of Central Vietnam's major oncology centres, with surgical oncology, medical oncology, radiotherapy and palliative care departments.

International patients researching the wider medical infrastructure can compare hospitals in Hanoi and hospitals in Ho Chi Minh City.

Thailand's biggest advantage is the international patient ecosystem

Thailand has treated international medical travellers for decades, and this experience is particularly visible in Bangkok's private hospital sector.

Large private hospitals commonly provide dedicated international patient departments, interpreters, overseas insurance coordination and structured systems for arranging consultations before a patient arrives in Thailand.

Bangkok also has dedicated private cancer facilities. Wattanosoth Hospital, part of Bangkok Hospital's network, operates medical oncology and radiation oncology services with multidisciplinary treatment involving oncologists, surgeons, radiologists and other specialists.

Bumrungrad International Hospital's Horizon Regional Cancer Center also treats international patients and provides systemic and radiation oncology services.

For someone travelling specifically for cancer treatment, the administrative side of care can therefore be easier to organise in Thailand.

That does not establish that the oncology itself is automatically better. It means Thailand has a particularly mature infrastructure around foreign patients.

Surgery: both countries can handle major cancer operations

Cancer surgery is available at major hospitals in both Vietnam and Thailand.

The more useful question is whether the proposed surgeon regularly operates on your specific tumour.

For complex procedures, compare:

• Surgeon experience with the cancer type.
• Number and complexity of similar operations performed.
• Intensive care support.
• Interventional radiology.
• Pathology services.
• Blood bank support.
• Management of postoperative complications.

A highly experienced Vietnamese surgeon treating a particular cancer can be a more appropriate choice than travelling to a famous Thai hospital without first identifying the relevant surgical specialist.

Conversely, a complex case may justify travelling if a particular multidisciplinary surgical team is available in Bangkok but difficult to access locally.

Radiotherapy is where hospital-level comparisons become especially important

Radiotherapy technology varies much more between hospitals than the broad labels Vietnam or Thailand suggest.

Vietnamese centres currently publish access to techniques including:

• IMRT.
• VMAT.
• IGRT.
• Stereotactic radiotherapy.
• SBRT.
• 4D radiotherapy at selected centres.

Vinmec describes techniques including 4D radiotherapy, VMAT, IMRT and SBRT within its oncology system. Hue Central Hospital also reports IMRT, VMAT, IGRT and stereotactic treatment capabilities.

Thailand has similarly advanced radiation oncology centres. Wattanosoth Hospital publishes technologies including IGRT, VMAT, brachytherapy and high-precision radiosurgery techniques. King Chulalongkorn Memorial Hospital also provides external beam radiation therapy and brachytherapy.

Rather than asking which country has better radiotherapy, ask:

1. Which radiation technique is recommended for my tumour?
2. Does the hospital routinely provide it?
3. How experienced is the team with my cancer type?
4. How soon can treatment start?
5. How many sessions will be required?

For a course lasting several weeks, location and accommodation also become important practical factors.

Chemotherapy is widely available in both countries

Standard chemotherapy is available across major oncology centres in Vietnam and Thailand.

For many common cancers, there may be little reason for a person already living in Vietnam to travel to Thailand simply to receive a standard regimen that is readily available locally.

The comparison becomes more relevant when the proposed treatment involves:

• An unusual regimen.
• A difficult-to-source drug.
• Complex supportive care.
• A clinical trial.
• Treatment after several previous therapies have failed.

Patients transferring between countries should bring a complete treatment record showing the exact drugs, doses, dates and adverse reactions from previous cycles.

Do not rely only on the commercial brand name of a chemotherapy medicine because brands can differ between countries.

Targeted therapy and immunotherapy narrow the gap

Modern oncology increasingly uses medicines chosen according to the biology of the tumour rather than only its location.

Both Vietnam and Thailand have hospitals offering targeted therapy and immunotherapy.

Vinmec publishes targeted treatment for multiple cancers and describes immunotherapy within its oncology programme. Hue Central Hospital also reports the use of targeted therapies and immunotherapy.

In Thailand, major private cancer centres provide medical oncology and immunotherapy for selected cancers, while the Thai National Cancer Institute also describes targeted treatment as part of modern cancer management.

Availability does not mean every medicine is immediately accessible at every hospital.

For expensive systemic therapy, confirm:

• Exact drug.
• Approved indication.
• Biomarker required.
• Cost per cycle.
• Expected number of cycles.
• Whether the medicine is stocked locally.
• Insurance coverage.

The cost of one infusion is much less useful than the expected cost of an entire treatment course.

Thailand generally wins on ease for a patient arriving from abroad

For a patient flying into Southeast Asia specifically for treatment, Thailand often has the easier international pathway.

Bangkok's major private hospitals are accustomed to handling:

• Pre-arrival medical record review.
• International appointment coordination.
• Interpreters.
• Private rooms.
• Overseas insurance.
• Airport and accommodation logistics.
• Medical reports in English.

Vietnam's private international hospitals increasingly provide similar support, but it is less consistently available across the country's oncology system.

Large Vietnamese public cancer hospitals may offer considerable clinical expertise while being less straightforward for a foreign patient unfamiliar with Vietnamese hospital administration or language.

This creates an important distinction: the hospital with the easiest international service is not necessarily the hospital with the strongest specialist for a particular cancer.

Vietnam can make more sense when you already live there

An expatriate or long-term resident in Vietnam should not assume that a cancer diagnosis means moving treatment to Thailand.

Cancer treatment frequently requires repeated appointments over months.

Remaining in Vietnam can make everyday care much easier because you may need:

• Weekly blood tests.
• Multiple chemotherapy cycles.
• Daily radiotherapy sessions.
• Postoperative checks.
• Medication adjustments.
• Urgent assessment for treatment side effects.

Continuity can matter more than having a more luxurious international patient department.

If an appropriate oncologist and treatment are available locally, receiving routine treatment near home while obtaining a second opinion from Thailand can sometimes be more practical than transferring the entire course of care.

Thailand becomes more attractive when a specific capability is missing

Travelling from Vietnam to Thailand becomes more rational when there is a clear medical reason.

Examples might include:

• A rare cancer requiring a specialist team.
• A complex operation not routinely performed locally.
• A particular radiation technique.
• A specific diagnostic or molecular test.
• Access to a drug that is difficult to obtain in Vietnam.
• A clinical trial.
• A second opinion after treatment failure.

The reason should be specific.

Saying "Thailand has better healthcare" is not enough to justify moving a complicated cancer treatment programme between countries.

Vietnam Clinic's broader comparison of healthcare in Vietnam and Thailand provides additional context on how the two private healthcare markets differ.

Costs are difficult to compare without a real treatment plan

Cancer treatment does not lend itself to useful country-wide price lists.

The cost may include:

• Pathology.
• Imaging.
• Molecular testing.
• Surgery.
• Hospitalisation.
• Chemotherapy.
• Targeted medicines.
• Immunotherapy.
• Radiotherapy.
• Blood products.
• Management of complications.
• Follow-up.

Private treatment in Vietnam will often be less expensive than treatment at Bangkok's premium international hospitals, particularly for consultations, hospital accommodation and some procedures.

But drugs can change that calculation. Many modern oncology medicines are internationally priced products, so a targeted therapy or immunotherapy course may remain expensive in either country.

A patient should obtain quotations for the same treatment plan before concluding that one country is cheaper.

Insurance can determine the decision before medicine does

For insured international patients, the hospital network may matter more than the difference between Vietnam and Thailand.

Some international policies provide direct billing at major hospitals in Bangkok while requiring reimbursement claims at other providers. Another policy may have strong arrangements in Vietnam.

Before planned treatment, confirm:

• Whether cancer is covered.
• Whether the diagnosis could be considered pre-existing.
• Annual coverage limit.
• Hospital network restrictions.
• Chemotherapy coverage.
• Radiotherapy coverage.
• Targeted therapy and immunotherapy coverage.
• Molecular testing coverage.
• Whether pre-authorisation is required.
• Whether treatment in another country is covered.

Vietnam Clinic's guide to choosing health insurance in Vietnam explains why policy limits and exclusions matter particularly for expensive long-term treatment.

Do not move countries without moving the medical record

Changing oncology teams requires more than carrying a discharge letter.

Ideally, provide the new hospital with:

• Pathology report.
• Pathology slides or tissue blocks when available.
• CT, MRI and PET imaging files.
• Radiology reports.
• Operation reports.
• Chemotherapy records.
• Radiotherapy treatment summary.
• Molecular and genetic results.
• Current medication list.
• Recent laboratory tests.

The new oncology team may want to review pathology or repeat selected investigations before changing treatment.

This is particularly important when the treatment decision depends on biomarkers or when several lines of therapy have already been used.

A second opinion does not require transferring your entire treatment

One practical option is to separate where you obtain the opinion from where you receive routine care.

For example, someone living in Ho Chi Minh City could receive an oncology assessment in Bangkok, obtain a recommendation and then discuss whether the treatment can safely be delivered in Vietnam.

This can work particularly well when the recommended chemotherapy or follow-up protocol is standard and accessible locally.

It is less useful when the reason for travelling is a procedure or technology only available at the destination hospital.

Before arranging international treatment, Medical Tourism in Vietnam: A Step-by-Step Guide covers practical issues involving records, quotations and follow-up that also apply when moving between regional healthcare systems.

What the cancer statistics do and do not tell you

IARC estimated 180,480 new cancer cases in Vietnam and 183,541 in Thailand in 2022. Despite Thailand's smaller population, the estimated total number of new cases was slightly higher.

The most frequently diagnosed cancers also differ somewhat. Across both sexes, Vietnam's three leading cancers were breast, liver and lung cancer, while Thailand's were liver, lung and breast cancer.

These statistics describe national cancer burden. They should not be used to decide where an individual will receive better treatment.

National incidence and mortality figures are influenced by prevention, screening, stage at diagnosis, population structure, access to treatment and many other factors. They do not provide a direct hospital-quality comparison.

Five situations where staying in Vietnam may be the better choice

Vietnam may be the more practical option when:

1. The required treatment is readily available at a major Vietnamese oncology centre.
2. You already live in Vietnam and need repeated treatment over several months.
3. Your established oncologist and support network are in Vietnam.
4. Your insurance provides better local coverage.
5. There is no specific clinical advantage to travelling.

Avoid making cancer care unnecessarily complicated purely because another country has a stronger medical tourism reputation.

Five situations where Thailand deserves a closer look

Thailand may deserve comparison when:

1. You need a specialist or technology that your Vietnamese team cannot provide.
2. You want another opinion on major or irreversible treatment.
3. You need highly organised international patient support.
4. Your insurance has better access to a Bangkok oncology centre.
5. A specific Thai hospital has documented expertise relevant to your tumour.

The key phrase is specific hospital. A decision between two named oncology teams is far more useful than a general Vietnam-versus-Thailand debate.

Build the comparison around these questions

Before deciding, ask both hospitals the same questions:

1. What exact diagnosis and stage are you treating?
2. Will my pathology be reviewed again?
3. Who will be my lead oncologist?
4. Will my case be discussed by a multidisciplinary tumour board?
5. What treatment do you recommend and why?
6. Is the required radiotherapy or surgical technology available?
7. Are all required drugs currently accessible?
8. When can treatment begin?
9. What is the expected total cost?
10. How many weeks or months must I remain locally?
11. How are emergencies handled between appointments?
12. Can follow-up continue in my home country or Vietnam?

A hospital that gives clear answers to those questions is more useful than one relying mainly on claims about being world-class or internationally recognised.

Frequently Asked Questions

The answers below address practical questions from international patients comparing cancer treatment in Vietnam and Thailand. Treatment decisions should be based on the individual cancer, oncology team and medical requirements rather than a general country ranking.

Conclusion

Vietnam and Thailand both provide modern cancer treatment, including surgery, chemotherapy, advanced radiotherapy, targeted therapy and immunotherapy at selected centres.

Thailand has the stronger international patient infrastructure overall, particularly within Bangkok's large private hospitals. That can make consultations, insurance coordination, English-language communication and treatment logistics easier for someone arriving from abroad.

Vietnam can be the more practical choice for people already living there, and major centres in Hanoi, Ho Chi Minh City and Hue provide increasingly sophisticated oncology care. For many standard cancer treatments, travelling to another country may offer little clinical advantage.

The deciding question should therefore be: which specific hospital and oncology team is best equipped for this cancer? Compare the recommended treatment, specialist experience, technology, waiting time, full cost and follow-up arrangements before choosing between Vietnam and Thailand.

Sources

1. International Agency for Research on Cancer: GLOBOCAN 2022 Viet Nam Fact Sheet
2. Hue Central Hospital: Oncology Center
3. Vinmec: Oncology Center
4. Thailand National Cancer Institute
5. King Chulalongkorn Memorial Hospital: Radiation Oncology Therapy Service
6. Wattanosoth Hospital: Medical Oncology Center
7. Bumrungrad International Hospital: Horizon Regional Cancer Center and Immunotherapy